Drugs / Unmanipulated Umbilical Cord Blood (UCB)
Unmanipulated Umbilical Cord Blood (UCB)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03483324 Background | Apr 2018 → Dec 2020 | acute lymphoblastic leukemia, acute myeloid leukemia, myelodysplastic syndrome | Angiocrine Bioscience | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Unmanipulated Umbilical Cord Blood (UCB) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03483324 ↗ |
| Modality | Cell therapy | “Human leukocyte antigen (HLA) matched umbilical cord blood” NCT03483324 ↗ |